Sangamo Therapeutics Inc (NASDAQ:SGMO)

19.05
Delayed Data
As of Apr 20
 -0.15 / -0.78%
Today’s Change
4.05
Today|||52-Week Range
27.50
+16.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues45.9M39.5M19.4M36.6M
 
 
 
 
 
Depreciation And Amortization549.0K988.0K997.0K1.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses71.9M85.3M91.0M91.4M
 
 
 
 
 
Research And Development56.7M67.1M65.6M65.7M
 
 
 
 
 
Total Operating Expenses72.4M86.3M91.9M92.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.6M-46.8M-72.6M-56.4M
 
 
 
 
 
Extraordinary Credit0.001.8M0.000.00
 
 
Extraordinary Charge-230.0K-1.9M0.000.00
 
 
 
Other Expenses0.00431.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.4M-46.4M-71.7M-54.6M
 
 
 
 
 
Income Taxes0.00-5.7M-14.0K0.00
 
 
 
Net Income-26.4M-40.7M-71.7M-54.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS67.0M69.8M70.6M78.1M
 
 
 
 
 
Shares To Calculate EPS Diluted67.0M69.8M70.6M78.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39-$0.58-$1.02-$0.70
 
 
 
 
 
EPS Diluted-$0.39-$0.58-$1.02-$0.70